STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Gold Reserve insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for GOLD RESERVE LTD in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Canadian issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM GDRZF
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
FY Dec 2019
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM GDRZF
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
FY Dec 2019
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM GDRZF
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
FY Dec 2019
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term debt only, 2017-12-31 (82 months older than the period end); equity 2024-09-30
Debt to equity GDRZF
FY Dec 2023
0.00x
FY Dec 2022
0.00x
FY Dec 2021
0.00x
FY Dec 2020
0.00x
FY Dec 2019
0.00x
Sep 2024
0.00x
Jun 2024
0.00x
Mar 2024
0.00x
Dec 2023
0.00x
Sep 2023
0.00x
Jun 2023
0.00x
Mar 2023
0.00x
Dec 2022
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt GDRZF
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
FY Dec 2019
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-21.5%
TTM net income over average of 2023-09-30 and 2024-09-30
Return on equity GDRZF
FY Dec 2023
-57.7%
FY Dec 2022
-15.4%
FY Dec 2021
-16.5%
FY Dec 2020
-15.6%
FY Dec 2019
n/a
Sep 2024
-21.5%
Jun 2024
-60.2%
Mar 2024
-60.1%
Dec 2023
-57.7%
Sep 2023
-56.5%
Jun 2023
-13.9%
Mar 2023
-14.9%
Dec 2022
-15.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-17.4%
TTM net income over average of 2023-09-30 and 2024-09-30
Return on assets GDRZF
FY Dec 2023
-49.9%
FY Dec 2022
-15.1%
FY Dec 2021
-16.3%
FY Dec 2020
-15.4%
FY Dec 2019
n/a
Sep 2024
-17.4%
Jun 2024
-51.7%
Mar 2024
-52.1%
Dec 2023
-49.9%
Sep 2023
-49.4%
Jun 2023
-13.6%
Mar 2023
-14.8%
Dec 2022
-15.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital GDRZF
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
FY Dec 2019
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed GDRZF
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
FY Dec 2019
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing GDRZF
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
FY Dec 2019
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$393.4M
market value at close 2026-10-27 on 2023-12-31 shares, plus long-term debt only, 2017-12-31 (82 months older than the period end), minus cash 2024-09-30
Enterprise value GDRZF
FY Dec 2023
$267.2M
FY Dec 2022
$111.0M
FY Dec 2021
$69.2M
FY Dec 2020
$101.6M
FY Dec 2019
$88.0M
Sep 2024
$106.7M
Jun 2024
$407.5M
Mar 2024
$290.9M
Dec 2023
$267.2M
Sep 2023
$245.5M
Jun 2023
$194.8M
Mar 2023
$113.8M
Dec 2022
$111.0M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield GDRZF
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
FY Dec 2019
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing GDRZF
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
FY Dec 2019
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
GDRZF ranks highest on financial health (99th percentile) and risk and compliance (99th), and lowest on profitability (42nd), among Mining & Metals peers.
Profitability
42
Inputs
Return on equity-21.5% · 38 pct, sector of 89
Return on assets-17.4% · 47 pct, sector of 114
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 80
Cash flow to debtno debt to cover
Risk and compliance
100
Inputs
Short interest, % of float+0.0% · 100 pct, sector of 252
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Growth, Insider conviction, Institutional and government, US patents
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.